ANIP - ANI Pharmaceuticals Inc. (ANIP) Q1 2024 Earnings Call Transcript
2024-05-10 14:14:13 ET
ANI Pharmaceuticals, Inc. (ANIP)
Q1 2024 Earnings Conference Call
May 10, 2024, 8:30 AM ET
Company Participants
Lisa Wilson - In-Site Communications, Investor Relations
Nikhil Lalwani - President and Chief Executive Officer
Stephen Carey - Senior Vice President, Finance and Chief Financial Officer
Conference Call Participants
Gary Nachman - Raymond James
Leszek Sulewski - Truist Securities
Vamil Divan - Guggenheim Securities
Oren Livnat - H.C. Wainwright
Timothy Chiang - Capital One
Presentation
Operator
Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2024 Earnings Results Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note this call is being recorded and I will be standing by if you should need any assistance.
It is now my pleasure to turn the conference over to Lisa Wilson.
Lisa Wilson
Thank you, Shelby. Welcome to ANI Pharmaceuticals Q1 2024 earnings results call. This is Lisa Wilson, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com.
Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation, or intent regarding future events and the company's future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act.
These forward-looking statements are based on information available to ANI Pharmaceuticals management as of today and involve risks and uncertainties, including those noted in our press release issued this morning and our filings with the SEC....
ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript